These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

144 related items for PubMed ID: 25865944

  • 1. De novo CSF3R mutation associated with transformation of myeloproliferative neoplasm to atypical CML.
    Bartels S, Lehmann U, Büsche G, Schlue J, Hussein K, Debatin D, Karcher A, Andrulis M, Schirmacher P, Kreipe H.
    Ann Hematol; 2015 Jul; 94(7):1255-6. PubMed ID: 25865944
    [No Abstract] [Full Text] [Related]

  • 2. [New mutations in myeloproliferative neoplasms; 2014 update].
    Kirito K.
    Rinsho Ketsueki; 2014 Oct; 55(10):1833-40. PubMed ID: 25297747
    [No Abstract] [Full Text] [Related]

  • 3. Oncogenic CSF3R mutations in chronic neutrophilic leukemia and atypical CML.
    Maxson JE, Gotlib J, Pollyea DA, Fleischman AG, Agarwal A, Eide CA, Bottomly D, Wilmot B, McWeeney SK, Tognon CE, Pond JB, Collins RH, Goueli B, Oh ST, Deininger MW, Chang BH, Loriaux MM, Druker BJ, Tyner JW.
    N Engl J Med; 2013 May 09; 368(19):1781-90. PubMed ID: 23656643
    [Abstract] [Full Text] [Related]

  • 4. [Molecular characterization of atypical chronic myeloid leukemia and chronic neutrophilic leukemia].
    Senín A, Arenillas L, Martínez-Avilés L, Fernández-Rodríguez C, Bellosillo B, Florensa L, Besses C, Álvarez-Larrán A.
    Med Clin (Barc); 2015 Jun 08; 144(11):487-90. PubMed ID: 24854193
    [Abstract] [Full Text] [Related]

  • 5. CSF3R is mutated in chronic neutrophilic leukemia and atypical CML.
    Cancer Discov; 2013 Jul 08; 3(7):OF23. PubMed ID: 23847367
    [Abstract] [Full Text] [Related]

  • 6. CSF3R mutated myeloid neoplasms: Beyond chronic neutrophilic leukemia.
    Mohamed A, Gao J, Chen YH, Abaza Y, Altman J, Jennings L, Vormittag-Nocito E, Sukhanova M, Lu X, Chen Q.
    Hum Pathol; 2024 Jul 08; 149():66-74. PubMed ID: 38879086
    [Abstract] [Full Text] [Related]

  • 7. Atypical Chronic Myeloid Leukemia in Two Pediatric Patients.
    Freedman JL, Desai AV, Bailey LC, Aplenc R, Burnworth B, Zehentner BK, Teachey DT, Wertheim G.
    Pediatr Blood Cancer; 2016 Jan 08; 63(1):156-9. PubMed ID: 26274939
    [Abstract] [Full Text] [Related]

  • 8. Atypical CML with mutated SRSF2, ASXL1, CSF3R, and MPL.
    Tran A, Wong M.
    Blood; 2021 Dec 30; 138(26):2890. PubMed ID: 34967865
    [No Abstract] [Full Text] [Related]

  • 9. The CSF3R T618I mutation as a disease-specific marker of atypical CML post allo-SCT.
    Langabeer SE, McCarron SL, Haslam K, O'Donovan MT, Conneally E.
    Bone Marrow Transplant; 2014 Jun 30; 49(6):843-4. PubMed ID: 24614839
    [No Abstract] [Full Text] [Related]

  • 10. Current and evolving understanding of atypical chronic myeloid leukemia.
    Schwartz LC, Mascarenhas J.
    Blood Rev; 2019 Jan 30; 33():74-81. PubMed ID: 30078497
    [Abstract] [Full Text] [Related]

  • 11. The new genetics of chronic neutrophilic leukemia and atypical CML: implications for diagnosis and treatment.
    Gotlib J, Maxson JE, George TI, Tyner JW.
    Blood; 2013 Sep 05; 122(10):1707-11. PubMed ID: 23896413
    [Abstract] [Full Text] [Related]

  • 12. The CSF3R T618I mutation causes a lethal neutrophilic neoplasia in mice that is responsive to therapeutic JAK inhibition.
    Fleischman AG, Maxson JE, Luty SB, Agarwal A, Royer LR, Abel ML, MacManiman JD, Loriaux MM, Druker BJ, Tyner JW.
    Blood; 2013 Nov 21; 122(22):3628-31. PubMed ID: 24081659
    [Abstract] [Full Text] [Related]

  • 13. Identification of a novel CSF3R-SPTAN1 fusion gene in an atypical chronic myeloid leukemia patient with t(1;9)(p34;q34) by RNA-Seq.
    Sheng G, Zhang J, Zeng Z, Pan J, Wang Q, Wen L, Xu Y, Wu D, Chen S.
    Cancer Genet; 2017 Oct 21; 216-217():16-19. PubMed ID: 29025591
    [Abstract] [Full Text] [Related]

  • 14. Analysis of CSF3R mutations in atypical chronic myeloid leukemia and other myeloid malignancies.
    Kim SY, Song IC, Kim J, Kwon GC.
    Ann Diagn Pathol; 2024 Aug 21; 71():152317. PubMed ID: 38642470
    [Abstract] [Full Text] [Related]

  • 15. A new allelic discrimination assay using locked nucleic acid-modified nucleotides (LNA) probes for detection of JAK2 V617F mutation.
    Marková J, Průková D, Volková Z, Schwarz J.
    Leuk Lymphoma; 2007 Mar 21; 48(3):636-9. PubMed ID: 17454614
    [No Abstract] [Full Text] [Related]

  • 16. CSF3R-mutant chronic myelomonocytic leukemia is a distinct clinically subset with abysmal prognosis: a case report and systematic review of the literature.
    Guastafierro V, Ubezio M, Manes N, Milanesi C, Della Porta M, Bonometti A.
    Leuk Lymphoma; 2023 Sep 21; 64(9):1566-1573. PubMed ID: 37395413
    [Abstract] [Full Text] [Related]

  • 17. What's different about atypical CML and chronic neutrophilic leukemia?
    Dao KH, Tyner JW.
    Hematology Am Soc Hematol Educ Program; 2015 Sep 21; 2015():264-71. PubMed ID: 26637732
    [Abstract] [Full Text] [Related]

  • 18. Next-generation sequencing reveals unique combination of mutations in cis of CSF3R in atypical chronic myeloid leukemia.
    Yun JW, Yoon J, Jung CW, Lee KO, Kim JW, Kim SH, Kim HJ.
    J Clin Lab Anal; 2020 Feb 21; 34(2):e23064. PubMed ID: 31692115
    [Abstract] [Full Text] [Related]

  • 19. Recent Progress in Chronic Neutrophilic Leukemia and Atypical Chronic Myeloid Leukemia.
    Dao KT, Tyner JW, Gotlib J.
    Curr Hematol Malig Rep; 2017 Oct 21; 12(5):432-441. PubMed ID: 28983816
    [Abstract] [Full Text] [Related]

  • 20. Genetically informed therapy in leukemia.
    Radich J.
    N Engl J Med; 2013 May 09; 368(19):1838-9. PubMed ID: 23656651
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.